EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial medicine: “from bench to bedside” 3PM-guided concept

Qianwen Shao, Marie Louise Ndzie Noah, Olga Golubnitschaja, Xianquan Zhan

EPMA Journal · 15.04.2025 · 16 (2) · 239-264

DOI: 10.1007/s13167-025-00409-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EPMA Journal, online erschienen am 15.04.2025. Verfasst von Qianwen Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Acad…. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are the primary sites for aerobic respiration and play a vital role in maintaining physiologic function at the cellular and organismal levels. Physiologic mitochondrial homeostasis, functions, health, and any kind of mitochondrial impairments are associated with systemic effects that are linked to the human health and pathologies. Contextually, mitochondria are acting as a natural vital biosensor in humans controlling status of physical and mental health in a holistic manner. So far, no any disorder is known as happening to humans independently from a compromised mitochondrial health as the cause (primary mitochondrial dysfunction) or a target of collateral damage (secondary mitochondrial injury). This certainty makes mitochondrial medicine be the superior instrument to reach highly ambitious objectives of predictive, preventive, and personalized medicine (PPPM/3PM). 3PM effectively implements the paradigm change from the economically ineffective reactive medical services to a predictive approach, targeted prevention and treatments tailored to individualized patient profiles in primary (protection against health-to-disease transition) and secondary (protection against disease progression) healthcare. Mitochondrial DNA (mtDNA) properties differ significantly from those of nuclear DNA (nDNA). For example, mtDNA as the cell-free DNA molecule is much more stable compared to nDNA, which makes mtDNA be an attractive diagnostic target circulating in human body fluids such as blood and tear fluid. Further, genetic variations in mtDNA contribute to substantial individual differences in disease susceptibility and treatment response. To this end, the current gene editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas, are still immature in mtDNA modification, and cannot be effectively applied in clinical practice posing a challenge for mtDNA-based therapies. In contrast, comprehensive multiomics technologies offer new insights into mitochondrial homeostasis, health, and functions, which enables to develop more effective multi-level diagnostics and targeted treatment strategies. This review article highlights health- and disease-relevant mitochondrial particularities and assesses involvement of mitochondrial medicine into implementing the 3PM objectives. By discussing the interrelationship between 3PM and mitochondrial medicine, we aim to provide a foundation for advancing early and predictive diagnostics, cost-effective targeted prevention in primary and secondary care, and exemplify personalized treatments creating proof-of-concept approaches for 3PM-guided clinical applications.

Schlagwörter

Stichwörter der Autor:innen

Autophagy and mitophagyCancerCardio-vascular diseaseChronic FatigueCost-effective tailored treatmentsEnvironmentHealth policyHealth-to-disease transitionIndividualized patient profileMetabolic diseaseMitochondrial medicineNeurodegenerationPredictive Preventive Personalized Medicine (PPPM / 3PM / 3P medicine)SignalingStress

Autor:innen und Institutionen

  • Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong 250117 People…
  • Predictive, Preventive and Personalised (3P) Medicine, University Hospital Bonn, Rheinische Friedrich-Wilhelms-University of Bonn, Venusberg Campus 1, 53127 Bonn, Germany.
  • Shandong Provincial Key Medical and Health Laboratory of Ovarian Cancer Multiomics, & Jinan Key Laboratory of Cancer Multiomics, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Aca…

Förderung

  • Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Shao, Q., Ndzie Noah, M. L., Golubnitschaja, O., & Zhan, X. (2025). Mitochondrial medicine: “from bench to bedside” 3PM-guided concept. EPMA Journal, 16(2), 239-264. https://doi.org/10.1007/s13167-025-00409-4

Vancouver

Shao Q, Ndzie Noah ML, Golubnitschaja O, Zhan X. Mitochondrial medicine: “from bench to bedside” 3PM-guided concept. EPMA Journal. 2025;16(2):239-264. doi:10.1007/s13167-025-00409-4

BibTeX
@article{Shao2025,
  author = {Shao, Qianwen and Ndzie Noah, Marie Louise and Golubnitschaja, Olga and Zhan, Xianquan},
  title = {Mitochondrial medicine: “from bench to bedside” 3PM-guided concept},
  journal = {EPMA Journal},
  year = {2025},
  volume = {16},
  number = {2},
  pages = {239--264},
  doi = {10.1007/s13167-025-00409-4}
}
Kostenlos starten →